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IN SITU IMPLANTATION OF A PROSTHETIC SYSTEMIC ATRIOVENTRICULAR VALVE IN CORRECTED
TRANSPOSITION
Amir Elami, MD, Arthur Pollak, MD, and Gideon Merin, MD, Jerusalem, Israel
Tricuspid valve abnormalities are common in patients with
corrected transposition of the great arteries (C-TGA).1-3
Anatomic abnormalities include Ebstein’s malformation,
straddling, dysplasia, or simply inferior displacement of the
coaptation point. As a consequence, systemic atrioventricular
valve insufficiency is common, occurring in up to 33% of
patients with C-TGA.3,4 This valvular dysfunction is signifi-
cant in that its presence or development negatively affects
survival, whether treated surgically or not.1,4,5 Systemic
(right) ventricular dysfunction often coexists in these
patients, making it difficult to define the relative contribution
of each abnormality to the progression of heart failure and
shortening of survival. In contrast to normally located regur-
gitant tricuspid valves, where even in the presence of
Ebstein’s anomaly over 50% can be repaired successfully,
left-sided tricuspid valves need to be replaced in most cases.
The conventional technique of valve replacement involves
excision, with loss of the continuity between the valve anu-
lus, valve tissue, chordae, and ventricular wall. Preservation
of the subvalvular apparatus has been shown to maintain left
ventricular performance after mitral valve replacement in
both animal models and clinical studies. We applied this con-
cept to 2 patients with C-TGA and tricuspid regurgitation
requiring tricuspid valve replacement (TVR).
Clinical summaries
PATIENT 1. This patient was born in June 1990. During the
first year of his life, he was hospitalized frequently because
of pulmonary infections as the result of congestive heart fail-
ure. Echocardiography identified C-TGA, a membranous
ventricular septal defect, a patent foramen ovale, mild pul-
monic stenosis, and significant tricuspid regurgitation caused
by Ebstein’s anomaly. Although dilated, right ventricular
(systemic) function was normal. At 3.5 years of age, he
underwent closure of the patent foramen ovale and ventricu-
lar septal defect, with implantation of a permanent atrioven-
tricular (DDD) pacemaker because of intermittent complete
atrioventricular block. Because he had normal right ventricu-
lar function at that time, it was decided to withhold surgical
intervention for the tricuspid valve. After this procedure he
remained asymptomatic for 12 months. He then started to
have shortness of breath, and cardiac enlargement was evi-
dent, despite full medical treatment of congestive heart fail-
ure. Echocardiography at 5 years of age revealed moderate
deterioration of systolic right ventricular function with frac-
tional shortening (FS) of 18%. Subsequently, he underwent
TVR. The septal leaflet of the valve was displaced down-
ward, and the anulus was dilated, thereby precluding leaflet
coaptation. A 27-mm St Jude Medical prosthesis (St Jude
Medical, Inc, St Paul, Minn) was implanted into the tricuspid
valve anulus. This was achieved by interrupted stitches that
ran from the atrial aspect through the anulus and around the
free edge of each leaflet and then into the prosthesis sewing
ring. The leaflets were therefore folded along the anulus.
When examined 1 month later, he denied any symptoms.
Echocardiography revealed improvement in right ventricular
function (FS, 23%) with a normally functioning prosthetic
valve. In addition, he regained sinus rhythm. During his last
follow-up visit, 29 months after TVR, echocardiography
demonstrated a normal size-for-age systemic ventricle with
mildly reduced systolic function (FS, 25%). 
PATIENT 2. This patient was initially diagnosed at the age of
6 months as having situs inversus and dextrocardia. A heart
murmur was also noted. In November 1992, when she was 53
years old, she started having shortness of breath on exertion.
Echocardiographic findings failed to diagnose C-TGA but
were instead read as severe “mitral regurgitation,” moderate
“tricuspid regurgitation,” and normal-size “left ventricle.”
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She remained in clinically stable condition for 2.5 years with
furosemide and enalapril. When she was aged 56 years, car-
diac catheterization revealed a pulmonary artery pressure of
90/10 mm Hg (mean, 60 mm Hg) and a pulmonary capillary
wedge pressure of 24 mm Hg. Right ventricular (systemic
ventricle) pressure was 92/12 mm Hg, and a grade 4/4 sys-
temic atrioventricular valve regurgitation was noted.
Systemic vascular resistance was 20.2 Wood units, and pul-
monary vascular resistance was 10.5 Wood units. Ultimately,
echocardiography confirmed the diagnosis of C-TGA with a
moderate decrease in systolic right ventricular function.
In November 1995, she underwent implantation of a 27-
mm St Jude Medical prosthesis into the dilated tricuspid
valve anulus, by the same technique as described for patient
1. Annuloplasty at the commissures (Kay) was used to repair
the mitral valve. Intraoperative transesophageal echocardiog-
raphy revealed residual grade 2/4 mitral valve regurgitation
(as compared with 4/4 before the operation). A sequential
atrioventricular pacemaker (DDD) was implanted for com-
plete heart block. Progressive clinical improvement to New
York Heart Association class I followed, with discontinuation
of enalapril 6 months after the operation. For the last 8
months, she has been in sinus rhythm. Serial echocardio-
graphic studies during the 29-month follow-up period
revealed progressive improvement in right ventricular size
and systolic function; the most recent study shows only a
mildly dilated ventricle with a mildly reduced contraction.
Discussion. Early death rate (10%) and late death rate
(20%) are high in patients with C-TGA and right ventricular
dysfunction who require TVR for systemic atrioventricular
valve insufficiency.6 The 5-year and 10-year survivals in
patients with an ejection fraction of less than 44% were 49%
and 19.5%, respectively, whereas 100% of patients with an
ejection fraction greater than 44% survived 5 and 10 years.6
This indicates that the proper timing for intervention should
be before the deterioration of systemic ventricular function.
For patients with atrioventricular concordance and mitral
insufficiency, left ventricular dysfunction often worsens after
mitral valve replacement in which the subvalvular apparatus
is not preserved. Although yet unproved by controlled stud-
ies, it is likely that the same mechanism of failure occurs with
the right ventricle in atrioventricular discordance. Preser-
vation of the subvalvular apparatus in patients with C-TGA
undergoing TVR should eliminate this mechanism as a factor
contributing to systemic ventricular deterioration. Although
the duration of follow-up for our 2 patients is rather short,
both of them enjoyed significant clinical improvement and
improved systemic ventricular function. Valve repair is a log-
ical alternative to valve replacement, obviating the need to
sacrifice the valve and subvalvular apparatus. However, this
has been performed only infrequently,5,6 and the long-term
durability of the repair, constantly exposed to systemic pres-
sures, is unknown.5 Another alternative to TVR in such
patients is the double switch operation, in which the morpho-
logic left ventricle becomes the systemic ventricle and atrial
blood is redirected accordingly. Such an approach assumes
the cumulative risk of preparatory pulmonary artery banding
(when necessary), the early and late risks of atrial and arteri-
al switch operations, and the late complications of conduits.7
More experience is necessary to demonstrate an advantage of
this approach over repair of the associated anomalies in C-
TGA with preservation of the subvalvular tricuspid valve
apparatus.
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